• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SC 13G/A filed by Brookdale Senior Living Inc.

    11/14/24 4:43:24 PM ET
    $BKD
    Hospital/Nursing Management
    Health Care
    Get the next $BKD alert in real time by email
    SC 13G/A 1 tm2428527d2_sc13ga.htm SC 13G/A

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    SCHEDULE 13G/A

     

    Under the Securities Exchange Act of 1934

     

    (Amendment No. 1)*

     

    Brookdale Senior Living Inc.
    (Name of Issuer)

     

    Common stock, $0.01 par value per share
    (Title of Class of Securities)

     

    112463104
    (CUSIP Number)

     

    August 26, 2024
     
    (Date of Event which Requires Filing of this Statement)

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

    ¨   Rule 13d-1(b)

     

    x  Rule 13d-1(c)

     

    ¨   Rule 13d-1(d)

     

    *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

     

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     

     

     

     

    SCHEDULE 13G

     

    CUSIP No. 112463104

     

    1

    Names of Reporting Persons

    Ventas, Inc.
    2

    Check the appropriate box if a member of a Group (see instructions)

    (a)  ¨

    (b)  ¨

    3 Sec Use Only

     

    4

    Citizenship or Place of Organization

    Delaware

    Number of Shares Beneficially Owned by Each Reporting Person With:

     

    5 Sole Voting Power
    11,873,607 (1)
    6 Shared Voting Power
    0
    7 Sole Dispositive Power
    11,873,607 (1)
    8 Shared Dispositive Power
    0
    9

    Aggregate Amount Beneficially Owned by Each Reporting Person

    11,873,607 (1)
    10

    Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    ¨
    11

    Percent of class represented by amount in row (9)

    5.96% (2)
    12

    Type of Reporting Person (See Instructions)

    CO

     

     

    (1) Ventas, Inc. holds a warrant to purchase 11,100,000 shares of the Issuer’s common stock and owns 773,607 shares of the Issuer’s common stock.

     

    (2) Calculation based on 199,212,529 shares of the Issuer’s common stock outstanding as of November 5, 2024, as reported in the Issuer’s Form 10-Q for the period ended September 30, 2024, 11,100,000 shares of the Issuer’s common stock which may be purchased under the warrant held by Ventas, Inc. and 773,607 shares of the Issuer’s common stock owned by Ventas, Inc.

     

     

     

     

    Item 1.

     

    (a) Name of Issuer: Brookdale Senior Living Inc.

     

    (b) Address of Issuer’s Principal Executive Offices:

     

    105 Westwood Place, Suite 400
    Brentwood, Tennessee 37027

     

    Item 2.

     

    (a) Name of Person Filing: Ventas, Inc.

     

    (b) Address of Principal Business Office or, if None, Residence:

     

    353 N. Clark Street, Suite 3300
    Chicago, Illinois 60654

     

    (c) Citizenship: Ventas, Inc. is a Delaware corporation.

     

    (d) Title of Class of Securities: Common stock, $0.01 par value per share

     

     

     

     

    (e) CUSIP No.: 112463104

     

    Item 3. If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

     

    (a)¨ Broker or dealer registered under Section 15 of the Act;

     

    (b)¨ Bank as defined in Section 3(a)(6) of the Act;

     

    (c)¨ Insurance company as defined in Section 3(a)(19) of the Act;

     

    (d)¨ Investment company registered under Section 8 of the Investment Company Act of 1940;

     

    (e)¨ An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);

     

    (f)¨ An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);

     

    (g)¨ A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);

     

    (h)¨ A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

     

    (i)¨ A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940;

     

    (j)¨ A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J);

     

    (k)¨ Group, in accordance with § 240.13d-1(b)(1)(ii)(K).

     

    If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution: ____

     

    Item 4. Ownership

     

    (a) Amount Beneficially Owned: 11,873,607 (3)

     

    (b) Percent of Class: 5.96% (4)

     

    (c) Number of shares as to which such person has:

     

    (i) Sole power to vote or to direct the vote:

     

    11,873,607 (3)

     

    (ii) Shared power to vote or to direct the vote:

     

    0

     

    (iii) Sole power to dispose or to direct the disposition of:

     

    11,873,607 (3)

     

    (iv) Shared power to dispose or to direct the disposition of:

     

    0

     

     

     

     

    Item 5. Ownership of Five Percent or Less of a Class.

     

    N/A.

     

    Item 6. Ownership of more than Five Percent on Behalf of Another Person.

     

    N/A.

     

    Item 7. Identification and classification of the subsidiary which acquired the security being reported on by the parent holding company or control person.

     

    N/A.

     

    Item 8. Identification and classification of members of the group.

     

    N/A.

     

    Item 9. Notice of Dissolution of Group.

     

    N/A.

     

    Item 10. Certifications.

     

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

     

     

    (3) Ventas, Inc. holds a warrant to purchase 11,100,000 shares of the Issuer’s common stock and owns 773,607 shares of the Issuer’s common stock.

     

    (4) Calculation based on 199,212,529 shares of the Issuer’s common stock outstanding as of November 5, 2024, as reported in the Issuer’s Form 10-Q for the period ended September 30, 2024, 11,100,000 shares of the Issuer’s common stock which may be purchased under the warrant held by Ventas, Inc. and 773,607 shares of the Issuer’s common stock owned by Ventas, Inc.

     

     

     

     

    SIGNATURE

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    Dated: November 14, 2024

     

    /s/ Carey S. Roberts  
    Name: Carey S. Roberts  
    Title: Executive Vice President, General Counsel, Ethics & Compliance Officer and Corporate Secretary  

     

    The original statement shall be signed by each person on whose behalf the statement is filed or such person’s authorized representative. If the statement is signed on behalf of a person by such person’s authorized representative other than an executive officer or general partner of the filing person, evidence of the representative’s authority to sign on behalf of such person shall be filed with the statement; provided, however, that a power of attorney for this purpose which is already on file with the Commission may be incorporated by reference. The name and any title of each person who signs the statement shall be typed or printed beneath such person’s signature.

     

    Attention: Intentional misstatements or omissions of fact constitute Federal criminal violations (See 18 U.S.C. 1001).

     

     

    Get the next $BKD alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $BKD

    DatePrice TargetRatingAnalyst
    4/1/2025$7.00Equal Weight
    Barclays
    10/16/2024$8.00Buy
    Jefferies
    10/7/2024$7.75 → $6.00Neutral → Underperform
    BofA Securities
    6/28/2024$7.50Outperform
    Macquarie
    12/15/2023$3.95 → $6.00Underperform → Neutral
    BofA Securities
    11/17/2023$7.00 → $9.00Sector Perform → Outperform
    RBC Capital Mkts
    1/17/2023$5.00 → $4.00Buy → Hold
    Stifel
    8/9/2021$7.00 → $8.00Sector Perform
    RBC Capital
    More analyst ratings

    $BKD
    SEC Filings

    See more
    • Amendment: Brookdale Senior Living Inc. filed SEC Form 8-K: Leadership Update

      8-K/A - Brookdale Senior Living Inc. (0001332349) (Filer)

      7/15/25 5:10:55 PM ET
      $BKD
      Hospital/Nursing Management
      Health Care
    • Brookdale Senior Living Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders

      8-K - Brookdale Senior Living Inc. (0001332349) (Filer)

      7/15/25 5:00:50 PM ET
      $BKD
      Hospital/Nursing Management
      Health Care
    • SEC Form 144 filed by Brookdale Senior Living Inc.

      144 - Brookdale Senior Living Inc. (0001332349) (Subject)

      7/10/25 3:23:25 PM ET
      $BKD
      Hospital/Nursing Management
      Health Care

    $BKD
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Hicks George T bought $50,307 worth of shares (9,140 units at $5.50), increasing direct ownership by 3% to 351,883 units (SEC Form 4)

      4 - Brookdale Senior Living Inc. (0001332349) (Issuer)

      3/6/24 4:27:18 PM ET
      $BKD
      Hospital/Nursing Management
      Health Care
    • Bumstead Frank M bought $5,360 worth of shares (1,000 units at $5.36), increasing direct ownership by 0.20% to 500,052 units (SEC Form 4)

      4 - Brookdale Senior Living Inc. (0001332349) (Issuer)

      2/23/24 4:28:41 PM ET
      $BKD
      Hospital/Nursing Management
      Health Care

    $BKD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Barclays initiated coverage on Brookdale Senior Living with a new price target

      Barclays initiated coverage of Brookdale Senior Living with a rating of Equal Weight and set a new price target of $7.00

      4/1/25 7:41:49 AM ET
      $BKD
      Hospital/Nursing Management
      Health Care
    • Jefferies initiated coverage on Brookdale Senior Living with a new price target

      Jefferies initiated coverage of Brookdale Senior Living with a rating of Buy and set a new price target of $8.00

      10/16/24 7:19:46 AM ET
      $BKD
      Hospital/Nursing Management
      Health Care
    • Brookdale Senior Living downgraded by BofA Securities with a new price target

      BofA Securities downgraded Brookdale Senior Living from Neutral to Underperform and set a new price target of $6.00 from $7.75 previously

      10/7/24 7:42:01 AM ET
      $BKD
      Hospital/Nursing Management
      Health Care

    $BKD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more

    $BKD
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Former Officer Hicks George T returned 67,970 shares to the company, decreasing direct ownership by 18% to 314,631 units (SEC Form 4)

      4 - Brookdale Senior Living Inc. (0001332349) (Issuer)

      5/22/25 4:20:59 PM ET
      $BKD
      Hospital/Nursing Management
      Health Care
    • Director Wielansky Lee S sold $68,235 worth of shares (10,000 units at $6.82), decreasing direct ownership by 4% to 223,836 units (SEC Form 4)

      4 - Brookdale Senior Living Inc. (0001332349) (Issuer)

      5/20/25 4:27:07 PM ET
      $BKD
      Hospital/Nursing Management
      Health Care
    • SEC Form 3 filed by new insider Hausman Joshua

      3 - Brookdale Senior Living Inc. (0001332349) (Issuer)

      5/2/25 4:59:17 PM ET
      $BKD
      Hospital/Nursing Management
      Health Care
    • Brookdale Announces Second Quarter 2025 Earnings Release and Conference Call Dates

      NASHVILLE, Tenn., July 23, 2025 /PRNewswire/ -- Brookdale Senior Living Inc. (NYSE:BKD) plans to release its second quarter 2025 financial results after the market closes on Wednesday, August 6, 2025. The Company also plans to discuss the results on a conference call scheduled for Thursday, August 7, 2025, at 9:00 a.m. (ET). BROOKDALE SENIOR LIVING - EARNINGS CALLDate: Thursday, August 7, 2025Time: 9:00 a.m. (ET) / 8:00 a.m. (CT) Call Within US: +1 (800) 715-9871Call Outside US: +1 (646) 307-1963Conference ID: 1482282 A webcast of the conference call will be available to the p

      7/23/25 6:45:00 AM ET
      $BKD
      Hospital/Nursing Management
      Health Care
    • Ortelius Comments on Results of Brookdale Senior Living Inc. Annual Meeting of Stockholders

      Ortelius' Public Campaign Has Driven Meaningful Change at Brookdale, Including the Dismissal of the Former CEO Ortelius Remains Committed to Holding the Board and Management Accountable for Performance and Actions to Maximize Value for Stockholders Ortelius Advisors, L.P. ("Ortelius") today issued the following statement in connection with its public campaign for change at Brookdale Senior Living Inc. (NYSE:BKD) ("Brookdale" or the "Company"), and the Company's Annual Meeting of Stockholders, which was held on July 11, 2025. Peter DeSorcy, Managing Member of Ortelius, said: "Ortelius' campaign served as an important catalyst for change at Brookdale, meaningfully impacting the Compan

      7/16/25 8:00:00 AM ET
      $BKD
      Hospital/Nursing Management
      Health Care
    • Brookdale Reports June 2025 Occupancy

      NASHVILLE, Tenn., July 8, 2025 /PRNewswire/ -- Brookdale Senior Living Inc. (NYSE:BKD) reported today its consolidated occupancy for June 2025.  June 2025 Observations: June consolidated occupancy results:Weighted average occupancy of 80.5% increased 230 basis points year-over-year and 50 basis points sequentially, reflecting occupancy acceleration during the quarter, which was driven both by higher move-ins and favorable move-out activity both year-over-year and sequentially.Month end consolidated occupancy was 82.2%, increasing 70 basis points sequentially and demonstrating continued strong demand and sales execution.June same community occupancy results:Weighted average occupancy of 81.1

      7/8/25 7:15:00 AM ET
      $BKD
      Hospital/Nursing Management
      Health Care

    $BKD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Brookdale Senior Living Inc.

      SC 13G/A - Brookdale Senior Living Inc. (0001332349) (Subject)

      11/14/24 4:43:24 PM ET
      $BKD
      Hospital/Nursing Management
      Health Care
    • Amendment: SEC Form SC 13G/A filed by Brookdale Senior Living Inc.

      SC 13G/A - Brookdale Senior Living Inc. (0001332349) (Subject)

      11/14/24 4:17:59 PM ET
      $BKD
      Hospital/Nursing Management
      Health Care
    • SEC Form SC 13G/A filed by Brookdale Senior Living Inc. (Amendment)

      SC 13G/A - Brookdale Senior Living Inc. (0001332349) (Subject)

      2/14/24 4:46:08 PM ET
      $BKD
      Hospital/Nursing Management
      Health Care

    $BKD
    Financials

    Live finance-specific insights

    See more
    • Brookdale Announces Second Quarter 2025 Earnings Release and Conference Call Dates

      NASHVILLE, Tenn., July 23, 2025 /PRNewswire/ -- Brookdale Senior Living Inc. (NYSE:BKD) plans to release its second quarter 2025 financial results after the market closes on Wednesday, August 6, 2025. The Company also plans to discuss the results on a conference call scheduled for Thursday, August 7, 2025, at 9:00 a.m. (ET). BROOKDALE SENIOR LIVING - EARNINGS CALLDate: Thursday, August 7, 2025Time: 9:00 a.m. (ET) / 8:00 a.m. (CT) Call Within US: +1 (800) 715-9871Call Outside US: +1 (646) 307-1963Conference ID: 1482282 A webcast of the conference call will be available to the p

      7/23/25 6:45:00 AM ET
      $BKD
      Hospital/Nursing Management
      Health Care
    • Ortelius Reaffirms Strategy to Unlock Sustainable Long-Term Value for Brookdale Senior Living Inc. Stockholders

      The Brookdale Board's Ongoing Missteps, Shortcomings, and Strategic Failures are Palpable, and Jeopardize the Company's Viability Contrary to the Current Board's Assertions, Ortelius' Strategy is Materially Different from the Company's Current Plans Ortelius' Nominees Would Restore Accountability at Brookdale, and Immediately Begin the Process of Substantial Value Generation for Stockholders Ortelius Advisors, L.P. ("Ortelius") today issued the following open letter to fellow stockholders of Brookdale Senior Living Inc. (NYSE:BKD)("Brookdale" or the "Company"), which further outlines that the judgement, execution, and decision-making abilities of Brookdale's current Board of Directors

      6/16/25 8:00:00 AM ET
      $BKD
      Hospital/Nursing Management
      Health Care
    • Ortelius Outlines Pathways to Build and Unlock Sustainable Long-Term Value for Brookdale Senior Living Inc. Stockholders

      Issues Letter to Stockholders that Identifies Multiple Paths to Value Creation for Brookdale Departure of Long Time CEO Cindy Baier in the Face of Ortelius' Campaign Just the First Step in Holding Board Accountable We Believe Ortelius' Nominees have the Skills and Experience Necessary to Oversee the Execution of Its Strategic Plan to Drive Real Change for Stockholders Ortelius Advisors, L.P. today issued the following open letter to fellow stockholders of Brookdale Senior Living Inc. (NYSE:BKD). The full text of the letter follows: April 24, 2025 Fellow Brookdale Senior Living Stockholders, Over the past seven years, investors in Brookdale Senior Living Inc. ("Brookdale" or the "Compa

      4/24/25 8:00:00 AM ET
      $BKD
      Hospital/Nursing Management
      Health Care

    $BKD
    Leadership Updates

    Live Leadership Updates

    See more
    • Ortelius Issues Final Call to Action for Brookdale Senior Living Inc. Stockholders and Encourages a Vote for Urgent Change

      Three Independent Proxy Advisors Recommend Stockholders Vote FOR Ortelius Nominees to Advance a Necessary Turnaround and End Years of Underperformance at Brookdale Vote FOR Ortelius' Nominees on the WHITE Proxy Card to Restore Accountability at Brookdale, and Immediately Begin the Process of Value Generation for Stockholders Ortelius Advisors, L.P. ("Ortelius") today issued the following open letter to fellow stockholders of Brookdale Senior Living Inc. (NYSE:BKD) ("Brookdale" or the "Company"), encouraging stockholders who have not yet voted to consider the current Board's abysmal performance, defensive tactics, dearth of responsibility, and questionable decision-making abilities. In i

      7/7/25 7:00:00 AM ET
      $BKD
      Hospital/Nursing Management
      Health Care
    • Ortelius Director Nominees Release Joint Letter to Brookdale Stockholders

      Ortelius Nominees Believe Brookdale Offers a Tremendous Value Creation Opportunity Under a Renewed Board and New Strategic Roadmap Six Highly Qualified and Independent Nominees Will Act with Urgency, Integrity, and Transparency to Increase Value for Stockholders Brookdale Stockholders are Urged to Vote the WHITE Proxy Card FOR all Six Ortelius Nominees Ortelius Advisors, L.P. ("Ortelius") today announced that the six highly qualified individuals nominated by Ortelius for election to the Board of Directors (the "Board") of Brookdale Senior Living Inc. (NYSE:BKD) ("Brookdale" or the "Company") at the upcoming 2025 Annual Meeting of Stockholders released a joint letter to Brookdale stock

      7/3/25 8:00:00 AM ET
      $BKD
      $GMRE
      $NTST
      $OHI
      Hospital/Nursing Management
      Health Care
      Real Estate Investment Trusts
      Real Estate
    • Glass Lewis Recommends Stockholders Vote for Change at Brookdale Senior Living Inc.

      Third Independent Proxy Advisor Confirms the Persuasive Case to Bolster Key Competencies on the Brookdale Board and Recommends Stockholders Vote FOR Ortelius Nominees to Advance a Necessary Turnaround Glass Lewis Identifies Governance Challenges at Brookdale Including the Persistent Lack of Accountability for Legacy Directors who have Overseen Poor Performance Furthering the Need for Board Renewal Ortelius Urges Brookdale Stockholders to Vote FOR all Six of Ortelius' Nominees on the WHITE Proxy Card Ortelius Advisors, L.P. ("Ortelius") today announced that a third leading independent proxy advisory firm, Glass, Lewis & Co. ("Glass Lewis"), has recommended that stockholders vote FOR th

      7/1/25 4:30:00 PM ET
      $BKD
      Hospital/Nursing Management
      Health Care